Table S1 from Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer
Elizabeth C. Wescott(Vanderbilt University Medical Center), Justin M. Balko(Vanderbilt University Medical Center), Laura van ‘t Veer, Elizabeth Claire Dees(University of North Carolina at Chapel Hill), Melinda E. Sanders(Vanderbilt University), Xiaopeng Sun(Vanderbilt University Medical Center), Lamorna Brown Swigart(University of California, San Francisco), Julia Wulfkuhle(University of California, San Francisco), Paula I. González-Ericsson(Breast Cancer Research Foundation), Jennifer A. Pietenpol(Vanderbilt University), Cesar A. Santa‐Maria(Johns Hopkins University), Violeta Sánchez(Vanderbilt University), John T. Wilson(Vanderbilt University), Henry Gómez, Susan R. Opalenik(Vanderbilt University), Rosa I. Gallagher(George Mason University), Tarah J. Ballinger(Indiana University Health), Claudine Isaacs(Georgetown University), Laura J. Esserman(University of California, San Francisco), Brian D. Lehmann(Vanderbilt University Medical Center), Brandie C. Taylor(Vanderbilt University Medical Center), Payal D. Shah(Rutgers, The State University of New Jersey), Vandana G. Abramson(Vanderbilt University), Gillian L. Hirst(University of California, San Francisco), Juliana Bronzini(Vanderbilt University), Ann Hanna(Vanderbilt University Medical Center), Emanuel F. Petricoin(Center for Biologics Evaluation and Research), Vijaya Bharti(Vanderbilt University)
Cited by 0
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
|New England Journal of Medicine|2019|1.3k
Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
|JNCI Journal of the National Cancer Institute|2012|1.1k